GB2112380A - A pyrimidone salt and its preparation - Google Patents

A pyrimidone salt and its preparation Download PDF

Info

Publication number
GB2112380A
GB2112380A GB08215404A GB8215404A GB2112380A GB 2112380 A GB2112380 A GB 2112380A GB 08215404 A GB08215404 A GB 08215404A GB 8215404 A GB8215404 A GB 8215404A GB 2112380 A GB2112380 A GB 2112380A
Authority
GB
United Kingdom
Prior art keywords
methyl
pyrimidone
ethylamino
imidazolylmethylthio
benzodioxolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB08215404A
Other languages
English (en)
Inventor
George Raymond White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of GB2112380A publication Critical patent/GB2112380A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Air-Conditioning For Vehicles (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB08215404A 1981-05-30 1982-05-26 A pyrimidone salt and its preparation Withdrawn GB2112380A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8116615 1981-05-30

Publications (1)

Publication Number Publication Date
GB2112380A true GB2112380A (en) 1983-07-20

Family

ID=10522169

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08215404A Withdrawn GB2112380A (en) 1981-05-30 1982-05-26 A pyrimidone salt and its preparation

Country Status (12)

Country Link
US (1) US4450161A (https=)
EP (1) EP0067579B1 (https=)
JP (1) JPS57206683A (https=)
AT (1) ATE9345T1 (https=)
AU (1) AU8431082A (https=)
DE (1) DE3260719D1 (https=)
DK (1) DK230482A (https=)
ES (1) ES512629A0 (https=)
GB (1) GB2112380A (https=)
GR (1) GR76450B (https=)
PT (1) PT74958B (https=)
ZA (1) ZA823766B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones

Also Published As

Publication number Publication date
DK230482A (da) 1982-12-01
ATE9345T1 (de) 1984-09-15
EP0067579A1 (en) 1982-12-22
PT74958B (en) 1983-12-23
US4450161A (en) 1984-05-22
DE3260719D1 (en) 1984-10-18
ES8304094A1 (es) 1983-02-16
ES512629A0 (es) 1983-02-16
GR76450B (https=) 1984-08-10
AU8431082A (en) 1982-12-09
JPS57206683A (en) 1982-12-18
EP0067579B1 (en) 1984-09-12
ZA823766B (en) 1983-04-27
PT74958A (en) 1982-06-01

Similar Documents

Publication Publication Date Title
TW420612B (en) Pharmaceutical composition for the treatment of HBV infection in a human or other host animal
US3818035A (en) 2{8 (2-ALKYLBENZO{8 b{9 {11 FURAN-3 yl)METHYL{9 -{66 {11 IMIDAZOLINE
EP4652167A1 (en) Glp-1r agonists and uses thereof
JPS60228477A (ja) ２‐アルコキシ‐ｎ‐（１‐アザビシクロ［２，２，２］オクト‐３‐イル）ベンズアミド類およびチオベンズアミド類
IE47798B1 (en) Substituted ortho-anisamides,methods of preparing them,compositions containing them and their application as psychotropic agents
KR20070050967A (ko) 4-[[(7ｒ)-8-사이클로펜틸-7-에틸-5,6,7,8-테트라하이드로-5-메틸-4-6-옥소-2-프테리디닐]아미노]-3-메톡시-ｎ-(1-메틸-4-피페리디닐)벤즈아미드의 수화물 및 다형체, 이들의제조방법, 및 약제로서의 이들의 용도
KR910015562A (ko) 뇌부전 질환치료용 약제, 신규 2-(1-피페라지닐)-4-페닐시클로알카노 피리미딘 유도체, 및 그의 제법
CN1387530A (zh) 用作磷酸二酯酶vii抑制剂的咪唑并吡啶衍生物
RU2043994C1 (ru) Глутатионалкиловые эфиры окисленного типа и способ их получения
US5506264A (en) Zinc tranexamate compounds
US4877794A (en) 2-Alkoxy-n-(1-azabicyclo(2.2.2)oct-3-yl) benzamide and thiobenzamide compositions and the use thereof to treat schizophrenia
US4450161A (en) Pyrimidone salt and its preparation
GB1583691A (en) Benzopyrans
HK1005033B (en) Stable solutions of rebeccamycin analog and preparation thereof
SK152095A3 (en) Crystalline (+) l-hydrogentartrate, preparation method thereof, pharmaceutical composition containing its and its use
US3923996A (en) 3-Substituted-oxindoles in compositions and methods of treating obesity
AU704115B2 (en) Zwitterionic forms of trovafloxacin
JPH0572903B2 (https=)
PL196046B1 (pl) Postać krystaliczna monohydratu cytrynianu (2S,3S)-N-(2-metoksy-5-t-butylofenylo)metylo-2-difenylometylo-1-azabicyklo[2.2.2]oktano-3-aminy, środek farmaceutyczny, zastosowanie tej postaci krystalicznej i sposób wytwarzania tej postaci krystalicznej
US4599346A (en) Propan-2-ol derivatives, a process for their production and medicaments containing these compounds
KR920006911B1 (ko) 안정한 피록시캄 주사액 조성물 및 그의 제조방법
US5387597A (en) Hemiphosphate hemihydrate of 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)thiazole
US2753340A (en) Maleate salts of protoveratrine a and protoveratrine b
US6303608B1 (en) 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use
EP0272849B1 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)